Expertise in
29
conditions

Dr. M B. Kahaleh

Rheumatology
University Of Toledo Physicians LLC
3355 Glendale Ave, 
Toledo, OH 
 (562.3 mi)
Accepting New Patients
Offers Telehealth
Expertise in
29
conditions
University Of Toledo Physicians LLC
3355 Glendale Ave, 
Toledo, OH 
 (562.3 mi)
OverviewInsuranceLocationsClinical Research

Overview

M Kahaleh is a Rheumatologist in Toledo, Ohio. Dr. Kahaleh is highly rated in 29 conditions, according to our data. His top areas of expertise are Scleroderma, Systemic Sclerosis (SSc), Raynaud Phenomenon, and Rheumatoid Arthritis (RA). Dr. Kahaleh is currently accepting new patients.

His clinical research consists of co-authoring 38 peer reviewed articles and participating in 6 clinical trials. MediFind looks at clinical research from the past 15 years.

Specialties
Rheumatology
Licenses
Internal Medicine in OH
Hospital Affiliations
University Of Toledo Medical Center
Mercy St Vincent Medical Center
Promedica Toledo Hospital
Fulton County Health Center
Languages Spoken
English
Arabic
Arabic - Jordanian
Gender
Male

Insurance

Please contact the provider to confirm they accept your insurance or if you don't see your insurance listed.

Accepted insurance plans

  •  Cigna
  •  Priority Health
  •  Blue Cross Blue Shield
  •  McLaren Health
  •  Medical Health
  •  CareSource

Locations

UNIVERSITY OF TOLEDO PHYSICIANS LLC
3355 Glendale Ave, Toledo, OH 43614

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

6 Clinical Trials

A Randomized, Double-Blind, Placebo-Controlled, Repeat-Dose, Multicenter Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics, and Explore Efficacy of TEPEZZA in Patients With Diffuse Cutaneous Systemic Sclerosis
A Randomized, Double-Blind, Placebo-Controlled, Repeat-Dose, Multicenter Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics, and Explore Efficacy of TEPEZZA in Patients With Diffuse Cutaneous Systemic Sclerosis
Enrollment Status: Terminated
Publish Date: June 28, 2024
Intervention Type: Biological, Other
Study Drug: Tepezza Anti-IGF-1 Receptor Monoclonal Antibody
Study Phase: Phase 1
A Phase 3, Double-Blind, Multicenter Study to Evaluate the Long-Term Safety and Efficacy of Baricitinib in Patients With Systemic Lupus Erythematosus (SLE)
A Phase 3, Double-Blind, Multicenter Study to Evaluate the Long-Term Safety and Efficacy of Baricitinib in Patients With Systemic Lupus Erythematosus (SLE)
Enrollment Status: Terminated
Publish Date: May 16, 2023
Intervention Type: Drug
Study Drug: Baricitinib
Study Phase: Phase 3
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Phase 3 Study of Baricitinib in Patients With Systemic Lupus Erythematosus
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Phase 3 Study of Baricitinib in Patients With Systemic Lupus Erythematosus
Enrollment Status: Completed
Publish Date: November 23, 2022
Intervention Type: Drug
Study Drug: Baricitinib
Study Phase: Phase 3
A Multicenter, Double-Blind, Randomized, Placebo-Controlled, Phase 3 Study Evaluating the Safety and Efficacy of Intravenous Iloprost in Subjects With Systemic Sclerosis Experiencing Symptomatic Digital Ischemic Episodes (AURORA Study)
A Multicenter, Double-Blind, Randomized, Placebo-Controlled, Phase 3 Study Evaluating the Safety and Efficacy of Intravenous Iloprost in Subjects With Systemic Sclerosis Experiencing Symptomatic Digital Ischemic Episodes (AURORA Study)
Enrollment Status: Completed
Publish Date: July 14, 2021
Intervention Type: Drug
Study Drug: Iloprost
Study Phase: Phase 3
A Multicenter, Randomized, Double-Blind, Placebo-Controlled Phase 3 Trial to Evaluate Efficacy and Safety of Lenabasum in Diffuse Cutaneous Systemic Sclerosis
A Multicenter, Randomized, Double-Blind, Placebo-Controlled Phase 3 Trial to Evaluate Efficacy and Safety of Lenabasum in Diffuse Cutaneous Systemic Sclerosis
Enrollment Status: Terminated
Publish Date: March 29, 2021
Intervention Type: Drug, Other
Study Phase: Phase 3
A Multicenter, Double-Blind, Randomized, Placebo-Controlled, Phase 2 Pilot Study Evaluating Intravenous Iloprost in Subjects With Symptomatic Raynaud's Phenomenon Secondary to Systemic Sclerosis
A Multicenter, Double-Blind, Randomized, Placebo-Controlled, Phase 2 Pilot Study Evaluating Intravenous Iloprost in Subjects With Symptomatic Raynaud's Phenomenon Secondary to Systemic Sclerosis
Enrollment Status: Completed
Publish Date: February 17, 2020
Intervention Type: Drug
Study Phase: Phase 2
View 5 Less Clinical Trials

38 Total Publications

Decreased prevalence and altered clinical phenotype of systemic sclerosis and other autoimmune connective tissue diseases in type 1 and type 2 diabetes: A cross-sectional observational study.
Decreased prevalence and altered clinical phenotype of systemic sclerosis and other autoimmune connective tissue diseases in type 1 and type 2 diabetes: A cross-sectional observational study.
Journal: Journal of scleroderma and related disorders
Published: August 06, 2024
Similar Doctors
Expertise in
7
conditions
Dr. John J. Varga
Rheumatology
Expertise in
7
conditions
Dr. John J. Varga
Rheumatology

Regents Of The University Of Michigan

1500 E Medical Ctr Dr, 
Ann Arbor, MI 
 (46.8 mi)
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

John Varga is a Rheumatologist in Ann Arbor, Michigan. Dr. Varga is highly rated in 7 conditions, according to our data. His top areas of expertise are Scleroderma, Systemic Sclerosis (SSc), Scleroma, and Localized Scleroderma. Dr. Varga is currently accepting new patients.

Expertise in
23
conditions
Dr. Nezam I. Altorok
Rheumatology
Expertise in
23
conditions
Dr. Nezam I. Altorok
Rheumatology

University Of Toledo Physicians LLC

3125 Transverse Dr, 
Toledo, OH 
 (0.4 mi)
419-383-5000
Experience:
16+ years
Languages Spoken:
English, Arabic, Arabic - Jordanian
See accepted insurances
Accepting New Patients
Offers Telehealth

Nezam Altorok is a Rheumatologist in Toledo, Ohio. Dr. Altorok has been practicing medicine for over 16 years is highly rated in 23 conditions, according to our data. His top areas of expertise are Scleroderma, Polymyalgia Rheumatica, Rhizomelic Pseudopolyarthritis, Endoscopy, and Gastrostomy. Dr. Altorok is currently accepting new patients.

Expertise in
7
conditions
Dr. Mariana J. Kaplan
Rheumatology
Expertise in
7
conditions
Dr. Mariana J. Kaplan
Rheumatology
1500 East Medical Center Dr, 3rd Floor Taubman Ctr Recp A, 
Ann Arbor, MI 
 (46.8 mi)
734-647-5900
Languages Spoken:
English

Mariana Kaplan is a Rheumatologist in Ann Arbor, Michigan. Dr. Kaplan is highly rated in 7 conditions, according to our data. Her top areas of expertise are Systemic Lupus Erythematosus (SLE), Boils, Arthritis, and Rheumatoid Arthritis (RA).

Areas of Expertise

When evaluating expertise, MediFind pulls from factors such as the number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

To learn more about how MediFind determines the expertise levels, check out our expert tiers page.

Search for your specific condition
Want to save this doctor for later?
Sign Up
Is this your doctor?
Find A Second Opinion
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile